InsiderSignal.AI

InsiderSignal.ai

AORT - Artivion, Inc.

Insider Sale by Davis John E (Chief Commercial Officer)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

4 days ago, Davis John E, serving as Chief Commercial Officer at Artivion, Inc. (AORT), sold 5,848 shares at $36.92 per share, for a total transaction value of $215,882.00. Following this transaction, Davis John E now holds 209,306 shares of AORT.

This sale represents a 3.00% decrease in Davis John E's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, February 23, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 25, 2026, 2 days after the trade was made.

Artivion, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Davis John E

Chief Commercial Officer

John E. Davis is the Chief Commercial Officer (also referred to as Senior Vice President, Chief Commercial Officer) at Artivion, Inc. (AORT), a medical device company focused on aortic disease treatments.[[1]](https://fintool.com/app/research/companies/AORT/people/john-e-davis)[[2]](https://artivion.com/about/) Appointed to this role in February 2024, he brings over 25 years of experience in sales and marketing within the medical devices industry, with prior roles at Medtronic and St. Jude Medical.[[1]](https://fintool.com/app/research/companies/AORT/people/john-e-davis)[[2]](https://artivion.com/about/) Davis, aged approximately 60, owns about 193,842 shares of Artivion stock, valued at over $8 million, and has been active in insider trading, including sales of 10,802 shares in August 2025 ($471,755), 5,000 shares in December 2025, and additional disposals reported in late 2025.[[3]](https://www.gurufocus.com/insider/84020/john-e-davis)[[5]](https://www.investing.com/news/insider-trading-news/artivions-chief-commercial-officer-davis-sells-471k-in-shares-93CH-4192720)[[6]](https://www.tradingview.com/news/tradingview:46dcc9628d609:0-artivion-s-chief-commercial-officer-sells-5-000-shares/)[[4]](https://www.sahmcapital.com/news/content/artivion-chief-commercial-officer-john-e-davis-reports-sale-of-common-shares-2025-12-17) His leadership contributes to Artivion's mission of partnering with surgeons to deliver innovative aortic technologies.[[2]](https://artivion.com/about/)

View full insider profile →

Trade Price

$36.92

Quantity

5,848

Total Value

$215,882.00

Shares Owned

209,306

Trade Date

Monday, February 23, 2026

4 days ago

SEC Filing Date

Wednesday, February 25, 2026

Filed 2 days after trade

HEALTHCAREMEDICAL DEVICES

About Artivion, Inc.

Company Overview

No company information available
View news mentioning AORT

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4297363

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime